Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: TMC647055HPC1001
Total 1 results
Tibotec Pharmaceuticals, Ireland
Completed
TMC647055HPC1001 - First-in-human Trial to Examine Safety, Tolerability and Pharmacokinetics (How the Drug is Absorbed Into the Bloodstream) of Increasing Single Oral Doses and of Increasing Repeated Oral Doses of TMC647055 in Healthy Volunteers and in Hepatitis C Virus Infected Patients
Hepatitis C
Belgium
Sponsors and Collaborators
University of Maryland, College Park
AQTIS Medical B.V.
Hebrew University
Clear Guide Medical Inc.
Department of Neurology and Neurosurgery, Brain Center, University Medical Center Utrecht
Sarah Capalla
NORTHAMPTONSHIRE HEALTHCARE NHS FOUNDATION TRUST
PhytoHealth Corporation
Hebei Hospital of Traditional Chinese Medicine
OLVG West Hospital, Amsterdam, the Netherlands
OSO-AI
Research Division of Clinical Biochemistry, Koege Hospital, Denmark
Instituto Dermatológico y Cirugía de Piel (IDCP)
Paolo Fogagnolo
Vascular Scientific, LLC
Paris 12 Val de Marne University
Xiaojun Xu
Trommsdorff GmbH & Co. KG
Semiha ALKAN KAYHAN
Federatie Medisch Specialisten
View Full List
Medical Conditions
CVD Risk
Long Term Neurobehavioral Effects
Dissection, Aortic
Sleep Disorder, Shift-Work
HPV-unrelated Head and Neck Squamous Cell Carcinoma
Cutaneous Metastatic Melanoma
Degloving Injury
Mouse Allergy
RVOT Anomaly
Non-specific Chronic Low Back Pain
Current Depressive Episode
Children With Complex Chronic Conditions
Invasive Group B Streptococcus Disease Among Non-pregnant Adult
Biliary and Pancreatic Stones
5 Years of Follow-up After Transplant, in Which an Attempt Was Made to Suspend IS
Age 50 - 74 for Females or 60-74 for Males
Heel Spur
Hematopoietic Stem Cell Transplant
Hospital Accreditation
Blasts 5 Percent or More of Peripheral Blood White Cells
View Full List
Drug Interventions
TAK-792 250 mg
Olanzapine
Mesenchymal stromal cells
Minirin
Capecitabine
Ombitasvir/paritaprevir/ritonavir
IV adminstration of EMI-137
AllerT full dose
LEV 2,5 mg/kg
Dapivirine Vaginal Ring-004 with no menses
Pyrotinib 400mg + Vinorelbine
Estrofem
AbobotulinumtoxinA
Trimethoprim-sulfamethoxazole
Ethinylestradiol/Gestodene (BAY86-5016)
18F- fluorodeoxyglucose
Gemcitabine
Raltegravir
Insulin intensive therapy: Human Insulin (Novolin-R, Novo Nordisk)
XL184
View Full List
CROs by country
Contract Research Organizations in Algeria
Contract Research Organizations in Austria
Contract Research Organizations in Benin
Contract Research Organizations in Brazil
Contract Research Organizations in Colombia
Contract Research Organizations in Cyprus
Contract Research Organizations in Ethiopia
Contract Research Organizations in Guinea
Contract Research Organizations in Japan
Contract Research Organizations in Luxembourg
Contract Research Organizations in Mauritius
Contract Research Organizations in Mongolia
Contract Research Organizations in United Arab Emirates
CRO list by country
CROs in Uruguay
ACROSS Global
Raras CRO
Estudios Clínicos Latinoamérica (ECLA)
SGS
TRIO
All CROs in Uruguay
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe